Abbott Labs Earnings, Revenue Beat in Q1
2022.04.20 14:51
Abbott Labs Earnings, Revenue Beat in Q1
Investing.com – Abbott Labs (NYSE:ABT) reported on Wednesday first quarter earnings that beat analysts’ forecasts and revenue that topped expectations.
Abbott Labs announced earnings per share of $1.73 on revenue of $11.9B. Analysts polled by Investing.com anticipated EPS of $1.47 on revenue of $11.04B.
Abbott Labs shares are down 14% from the beginning of the year, still down 15.86% from its 52 week high of $142.60 set on December 27, 2021. They are under-performing the S&P 500 which is down 6.38% from the start of the year.
Abbott Labs shares gained 1.03% in pre-market trade following the report.
Abbott Labs follows other major Healthcare sector earnings this month
Abbott Labs’s report follows an earnings beat by UnitedHealth on April 14, who reported EPS of $5.49 on revenue of $80.15B, compared to forecasts EPS of $5.38 on revenue of $78,786M.
J&J had beat expectations on Tuesday with first quarter EPS of $2.67 on revenue of $23.43B, compared to forecast for EPS of $2.59 on revenue of $23.69B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar
